Capsugel

Founded in 1931, Capsugel, now a Lonza company, is a prominent entity in the Pharmaceuticals and Healthcare industries. The company specializes in the design, development, and manufacturing of innovative dosage forms for the biopharmaceutical and consumer health and nutrition sectors. With a rich history spanning nearly a century, Capsugel has established itself as a key player in delivering advanced solutions for drug delivery and product formulation. Its expertise encompasses a wide spectrum of services, from early-stage development and clinical trial support to commercial manufacturing and specialized packaging solutions.

Capsugel operates with a significant global footprint, managing 8 locations worldwide. The company's core offerings include hard capsules, advanced drug delivery systems, and contract manufacturing services tailored to meet specific client needs. Their manufacturing facilities are equipped to handle complex processes, ensuring high quality and compliance with stringent industry standards. The team at Capsugel is dedicated to innovation and customer assistance, providing integrated expertise across the entire product lifecycle. This commitment extends to developing specialized technologies that enhance drug efficacy and patient compliance, supporting the development of novel therapeutics and health products.

The company generates substantial revenue, reported at $4.9B, and employs a workforce ranging from 5,000 to 10,000 individuals. Capsugel competes in a dynamic market against firms such as Catalent, Piramal Pharma Solutions, and Cambrex, among others. Its strategic focus on innovation, quality, and comprehensive service offerings positions it as a vital partner for biopharmaceutical and consumer health companies seeking to bring their products to market efficiently and effectively. The company's extensive productView more...